| Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells U Joshi, N Filipczak, MM Khan, SA Attia, V Torchilin International Journal of Pharmaceutics 590, 119915, 2020 | 52 | 2020 |
| Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy MM Khan, A Madni, N Filipczak, J Pan, M Rehman, N Rai, SA Attia, ... Nanomedicine: Nanotechnology, Biology and Medicine 28, 102228, 2020 | 46 | 2020 |
| Efficient selective 4-aminophenol sensing and antibacterial activity of ternary Ag 2 O 3· SnO 2· Cr 2 O 3 nanoparticles MA Subhan, SS Jhuma, PC Saha, MM Alam, AM Asiri, M Al-Mamun, ... New Journal of Chemistry 43 (26), 10352-10365, 2019 | 39 | 2019 |
| Advances in siRNA delivery strategies for the treatment of MDR cancer MA Subhan, SA Attia, VP Torchilin Life Sciences 274, 119337, 2021 | 32 | 2021 |
| Monoclonal antibody 2C5-modified mixed dendrimer micelles for tumor-targeted codelivery of chemotherapeutics and siRNA J Pan, SA Attia, MA Subhan, N Filipczak, LP Mendes, X Li, ... Molecular Pharmaceutics 17 (5), 1638-1647, 2020 | 31 | 2020 |
| Hypoxia-sensitive drug delivery to tumors N Filipczak, U Joshi, SA Attia, IB Fridman, S Cohen, T Konry, V Torchilin Journal of Controlled Release 341, 431-442, 2022 | 17 | 2022 |
| Dendrimers for drug delivery purposes J Pan, SA Attia, N Filipczak, VP Torchilin Nanoengineered Biomaterials for Advanced Drug Delivery, 201-242, 2020 | 10 | 2020 |
| Targeted siRNA nanotherapeutics against breast and ovarian metastatic cancer: a comprehensive review of the literature A Subhan, SA Attia, V P Torchilin Nanomedicine 17 (1), 41-64, 2022 | 2 | 2022 |
| Modification of Nanoparticles with Transferrin for Targeting Brain Tissues SA Attia, X Li, N Filipczak, DF Costa, VP Torchilin Peptide Conjugation: Methods and Protocols, 49-56, 2021 | 1 | 2021 |
| Parameters and Strategies to Overcome Barriers to Systemic Delivery R Narayanaswamy, SA Attia, VP Torchilin Systemic Delivery Technologies in Anti-Aging Medicine: Methods and …, 2020 | 1 | 2020 |
| Page Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy MM Khan, A Madni, N Filipczak, J Pan, M Rehman, N Rai, SA Attia, ... | | |
